In last trading session, ENDRA Life Sciences Inc (NASDAQ:NDRA) saw 1.4 million shares changing hands with its beta currently measuring 0.17. Company’s recent per share price level of $3.78 trading at $0.69 or 22.52% at ring of the bell on the day assigns it a market valuation of $2.12M. That closing price of NDRA’s stock is at a discount of -17487.83% from its 52-week high price of $664.82 and is indicating a premium of 21.43% from its 52-week low price of $2.97. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.45 million shares which gives us an average trading volume of 89.16K if we extend that period to 3-months.

For ENDRA Life Sciences Inc (NDRA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -3.91 in the current quarter.

ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information

Upright in the green during last session for gaining 22.52%, in the last five days NDRA remained trading in the green while hitting it’s week-highest on Thursday, 04/17/25 when the stock touched $3.78 price level, adding 32.26% to its value on the day. ENDRA Life Sciences Inc’s shares saw a change of -39.62% in year-to-date performance and have moved 19.62% in past 5-day. ENDRA Life Sciences Inc (NASDAQ:NDRA) showed a performance of -15.81% in past 30-days. Number of shares sold short was 31580.0 shares which calculate 3.7 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 76.64% during past 5 years.

ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders

Insiders are in possession of 0.14% of company’s total shares while institution are holding 0.02 percent of that, with stock having share float percentage of 0.02%. Investors also watch the number of corporate investors in a company very closely, which is 0.02% institutions for ENDRA Life Sciences Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 690.0 shares of worth $2608.0 or 0.12% of the total outstanding shares. The later fund manager was in possession of 34.0 shares on Feb 28, 2025 , making its stake of worth around $128.0 in the company or a holder of 0.01% of company’s stock.